WHO ICTRP trial
Diabetes mellitus - II - Homoepathy
CTRI/2024/05/068127 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/05/068127 |
|---|---|
| Public title | Diabetes mellitus - II - Homoepathy |
| Scientific title | Management of Diabetes Mellitus Type 2 with Homoeopathic Medicines selected by Using Synthesis Repertory and Preparation of Repertory of Diabetes and Therapeutics for the same - DMSR |
| Primary sponsor | Rajkot Homoeopathic medical College |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases |
| Interventions | Intervention1: Individualised Homoeopathic medicine: Individualised Homoeopathic medicine selected by using synthesis Repertory. Mode of administration:Oral(sublingual) it will be administered for 9 months until any observable modification… |
| Registration date | May 30, 2024 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: